Arrowhead Pharmaceuticals, Inc.
看多

$ARWR Data Catalyst to start September

64
Like shares, leaps, and September 20th 25C's at .65 a contract

RNA company with one of the largest pipelines in the industry, biotech sector likely to see a tailwind in markets with rates coming down over the next 12 months

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。